Onkološki inštitut Ljubljana (OILJ)
  • Erlotinib in patients with advanced non-small cell lung cancer (NSCLC) : results on 149 patients from Tarceva rash management in lung (TRAIL) study
    Vrankar, Martina ...
    Vrsta gradiva - prispevek na konferenci
    Leto - 2010
    Jezik - angleški
    COBISS.SI-ID - 1035131